4OFU image
Entry Detail
PDB ID:
4OFU
Title:
Crystal structure of AR-LBD bound with co-regulator peptide
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2014-01-15
Release Date:
2014-08-20
Method Details:
Experimental Method:
Resolution:
2.12 Å
R-Value Free:
0.26
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Androgen receptor
Mutations:R760A
Chain IDs:A
Chain Length:250
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:co-regulator peptide
Chain IDs:B
Chain Length:12
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.
Mol Oncol 8 1575 1587 (2014)
PMID: 25091737 DOI: 10.1016/j.molonc.2014.06.009

Abstact

Treatment with individual anti-androgens is associated with the development of hot-spot mutations in the androgen receptor (AR). Here, we found that anti-androgens-mt-ARs have similar binary structure to the 5α-dihydrotestosterone-wt-AR. Phage display revealed that these ARs bound to similar peptides, including BUD31, containing an Fxx(F/H/L/W/Y)Y motif cluster with Tyr in the +5 position. Structural analyses of the AR-LBD-BUD31 complex revealed formation of an extra hydrogen bond between the Tyr+5 residue of the peptide and the AR. Functional studies showed that BUD31-related peptides suppressed AR transactivation, interrupted AR N-C interaction, and suppressed AR-mediated cell growth. Combination of peptide screening and X-ray structure analysis may serve as a new strategy for developing anti-ARs that simultaneously suppress both wt and mutated AR function.

Legend

Protein

Chemical

Disease

Primary Citation of related structures